Ahmed A. Othman
Gilead Sciences (United States)(US)Saarland University(DE)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Rheumatoid Arthritis Research and Therapies, Liver Disease Diagnosis and Treatment, Drug Transport and Resistance Mechanisms, Aortic Disease and Treatment Approaches
Most-Cited Works
- → Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study(2013)684 cited
- → Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial(2019)348 cited
- → Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease(2020)303 cited
- → Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis(2020)272 cited
- → Efficacy and Safety of ABT‐494, a Selective JAK‐1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate(2016)201 cited
- → A Phase IIb Study of ABT‐494, a Selective JAK‐1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti–Tumor Necrosis Factor Therapy(2016)182 cited